Zeus Capital advised Arcis Altos Group on its pre IPO fundraise following on from the successful £3.7m acquisition of Altos Medical LLC and £2.8m fund raise in May 2012.
Arcis, headed by Peter Whitehurst, a former director of SSL International, produces environmentally-friendly clearing and germ-killing products for diverse markets and has an antimicrobial technology which enables the ultra-fast killing of potentially difficult pathogens such as C-Difficle, TB and Norovirus through cleansing and cleaning applications.
Zeus where early stage investors in Arcis and over the last two years have been the lead adviser as the Company has developed. Last month Arcis won Deal of the Years (sub £5million) for the Acquisition of Altos Medical at the North West Business Insider Dealmaker Awards 2012.
Ross Andrews and Nick Cowles of Zeus Capital said: "We are delighted to have been involved with Arcis as early investors and through its transformation over the last 2 years leading to this latest fund raise prior to the Company's IPO in 2013."